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Microcirculatory Analysis in the Management  
of Sepsis—Occam’s Razor or Achilles’ Heel?*
An important feature of critical care–based research is the continual advance in the understanding of the variabil-ity of the human responses and the shifting importance 
of disease biomarkers and their clinical trajectories. The inhala-
tion of nitric oxide (INO) has become a particularly popular 
procedure in the intensive care, partly because gas delivery to 
the ventilated patient is relatively easy and partly because this 
administration route offers a number of advantages for lung-
directed therapies. Indeed, INO is used traditionally to treat 
a variety of conditions marked by hypoxemia secondary to 
persistent pulmonary hypertension (1). INO was additionally 
thought to improve ventilation perfusion by regional vasodi-
lation and was therefore usually used as selective pulmonary 
vasodilator in patients with acute respiratory distress syndrome 
(1, 2). In contrast with previous knowledge, however, distant 
extrapulmonary effects of INO have also been demonstrated, 
probably due to the nitrosylation of plasma proteins and hemo-
globin and the formation of nitrite, all of which can improve 
the systemic microcirculation, as demonstrated by increases in 
peripheral functional capillary density in patients with hypox-
emic respiratory failure (3). Logically, this suggests that INO 
can also be a method of choice for systemic microcirculatory 
resuscitation and that the use of INO can be extended as a treat-
ment option for sepsis, where a microcirculatory dysfunction is 
the key component of the pathogenesis (4, 5).
Nevertheless, there are probably more areas with gaps than 
confluence in this respect. A recent review revealed that INO 
can unquestionably improve the level of oxygenation, but 
does not reduce the mortality in patients with acute respi-
ratory distress syndrome, regardless of the severity (6). Fur-
thermore, IV formulations of nitric oxide (NO) donors, such 
as nitroglycerine, did not promote the sublingual microcircu-
latory blood flow in septic shock patients with hemodynamic 
resuscitation (7).
The article by Trzeciak et al (8) in this issue of Critical Care 
Medicine now offers deeper insight into the effects and limita-
tions of INO therapy in sepsis. The well-chosen aim of this 
randomized, controlled clinical study was to observe whether 
INO would improve the peripheral microcirculation in sep-
tic patients whose macrocirculation has been optimized with 
goal-directed therapy, and whether such microcirculatory 
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changes would be associated with an improved organ func-
tion, as assessed by the Sequential Organ Failure Assessment 
score. The primary outcome measure was a change in sublin-
gual microcirculation visualized through standard sidestream 
dark-field (SDF) videomicroscopy. Interestingly, the inhala-
tion of 40 ppm NO increased the plasma nitrite level signifi-
cantly, which suggests that NO was delivered systemically and 
might therefore exert distant microcirculatory effects. How-
ever, the interim analysis led to the termination of the trial for 
futility, in view of the lack of increase in the microcirculatory 
indices. This dose of NO did not augment the microcircula-
tory flow index (MFI) or the flow heterogeneity index (FHI) as 
measured by SDF imaging 2 hours after drug administration. 
Likewise, no association was found between the microcircula-
tory variables and the multiple organ dysfunction scores in the 
INO-treated patient population with sepsis.
This is a welcome study by an authoritative group of clini-
cians who have provided a conclusion that is absolutely relevant 
and logical: INO did not exert any significant influence on the 
sublingual microcirculation after resuscitation and the rela-
tion between INO, the sublingual microcirculatory perfusion, 
and multiple organ failure was therefore not confirmed either. 
The possible early microcirculatory consequences of INO are 
still open to discussion, but the interpretation of these find-
ings is well balanced. It may be added that it is perhaps timely 
to address a somewhat overlooked issue, the analysis method 
used to quantify the peripheral microcirculatory changes.
Although a clear consensus has been reached that a 
microcirculatory dysfunction is a pivotal element of critical 
conditions, the diagnostic power of bedside microcircula-
tory analyses remains less clear. The terms such as “impaired 
microcirculation” that are commonly used to describe sepsis or 
ischemia-induced changes tend to be simplistic and may rather 
misleadingly suggest that the microcirculatory responses are 
uniform in nature and similar in extent, whereas pathological 
microcirculatory alterations can range from transient reduc-
tions in capillary red cell traffic with a temporarily reduced 
velocity to complete capillary stasis with a decreased func-
tional capillary density. A sepsis-induced microvascular failure 
critically involves a flow redistribution, leading to diverse spa-
tial perfusion heterogeneity in distinct anatomical structures, 
including the wall of the gastrointestinal tract. To add to the 
complexity, a second form of perfusion heterogeneity may also 
be present when time-varying flow fluctuations evolve within 
the microvascular system.
Continuous or sustained microcirculatory events are easily 
compared, but this is certainly not the situation for alternating 
flow conditions in most cases. Not surprisingly, microcircula-
tory analysis is an extremely difficult task because the conven-
tional variables of spatial heterogeneity (such as functional 
capillary density) and timewise heterogeneity (such as cycles/
min) are insufficiently sensitive to allow subtle microcirculatory 
alterations to be followed. Further, the comparison of velocities 
between continuous flow and pulsatile perfusion phases and 
between different flow patterns is usually impossible by these 
means, even under well-controlled experimental conditions.
Orthogonal polarization spectral (OPS) imaging and its suc-
cessor, SDF imaging, have made microcirculatory investigations 
possible at the bedside, and videomicroscopy now provides 
easy-to-use approaches with which to recognize peripheral 
microcirculatory complications in a number of disease pro-
cesses. The diagnostic value of the intravital imaging technique 
has been clearly demonstrated in sepsis too (5). Direct visual-
ization of the sublingual microcirculation has become feasible 
and simple, but the complexity of the problem to be analyzed 
has not changed. Following OPS or SDF image acquisition, an 
in-depth analysis of the microcirculation, including the calcu-
lation of functional capillary density or the measurement of 
velocities, can be performed in individual vessels through the 
use of appropriate software tools. In view of the fact that this 
approach requires eye-challenging and time-consuming work, 
automated velocity measurements and new perfusion indica-
tors have been introduced in the clinical routine. After the use 
of “absent, intermittent, sluggish, and normal” flow to charac-
terize MFI was recommended by a consensus panel of experts 
(10), many clinical studies have used MFI or other perfusion 
markers, mostly with regard to their relative simplicity and 
reduced analysis time. However, “absent, intermittent, sluggish, 
and normal” are certainly not quantitative variables, and even 
a numerical derivative such as the FHI (the highest to lowest 
ratio of MFI at the observation site) is also a basically qualitative 
descriptor of the microcirculatory perfusion.
In the study by Trzeciak et al (8), the MFI was used to char-
acterize the quality of the flow in the groups of vessels present 
in the quadrants of the observation area. When the movement 
of red cells in certain capillaries slows or ceases, the MFI may 
include perfused and underperfused vessels and (without diam-
eter limitations) arterioles, venules, and capillaries too. The 
median value of MFI at 0 hour was 1.9 (1.7–2.1) for all groups 
of patients and was not changed significantly following INO or 
sham treatment. No flow is awarded a score of 0, intermittent 
flow a score of 1, sluggish flow a score of 2, and normal flow 
a score of 3. This means that the sublingual microcirculation 
was “generally sluggish” in these patients and remained “slug-
gish” after INO administration. Somewhat similarly, when the 
capillary refill time was first described in 1947, the definitions 
“normal,” “definite slowing,” and “very sluggish” were used to 
correlate the changes accompanying no, slight/moderate, or 
severe shock states, respectively (10). This does not disqualify 
the conclusion that INO is not associated with an improved 
patient outcome, but the effects on the oral microcirculation 
are perhaps less clear and subtle changes in microvascular per-
fusion may definitely not be ruled out. It should perhaps be 
emphasized that changes which may be subtle numerically are 
not always unimportant physiologically. Admitting this limi-
tation, it seems clear that the peripheral microcirculation was 
grossly unaffected in these patients, which does indeed restrict 
the rationale of INO administration in resuscitated sepsis.
The available clinical techniques cannot provide a complete 
view of the tissue microcirculation, and none of the techniques 
available for the evaluation of complex microvascular reac-
tions are perfect. Intravital microscopy serves as a good basis 
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for estimation of the in situ microcirculatory reactions, but 
a number of factors may affect the reliability of OPS or SDF 
measurements, and the analytical method for oral microcir-
culatory perfusion remains a limiting factor too. The simplic-
ity of an answer as demanded by William of Occam may be 
desirable as a principle, but accuracy is also important. Novel 
approaches through which to express numerical changes in 
microvascular perfusion, including heterogeneity, are surely 
needed.
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Prognosis After Cardiac Arrest: Time to Rethink 
Why, How, and When*
Why rush to prognosticate after cardiac arrest? Cer-tainly, there is less pressure to issue a rapid and definitive opinion about the long-term prospects of 
a patient with multitrauma, severe acute respiratory distress 
syndrome, or septic shock and multiple organ system fail-
ure. When confronted with such diseases, most of us would 
not hesitate, in the absence of futility, advanced age, or severe 
medical comorbidities, to treat aggressively for a week or more 
before issuing a formal opinion about prognosis. Yet after car-
diac arrest, there has evolved in some centers a practice of early 
prognostication. As demonstrated by the research of Mulder 
et al (1) published in this issue of Critical Care Medicine, that 
practice should be reconsidered.
Mulder et al (1) prospectively evaluated 154 comatose sur-
vivors of witnessed out-of-hospital cardiac arrest (OHCA) 
admitted to Hennepin County Medical Center. Seventy-seven 
percent of those patients were treated with hypothermia, and 
of the 78 patients (51%) who died, 81% died after withdrawal 
of life-sustaining therapy. Thirty percent of patients (19 of 63) 
who died had life support withdrawn within the first 72 hours 
of therapy, including five treated with therapeutic hypothermia. 
Yet among survivors, awakening after 72 hours was common 
(20 of 56; 36%). This demonstrates both the frequency of with-
drawal of life support measures as a mechanism of death after 
cardiac arrest and the need to allow more than 3 days for neu-
rological recovery prior to terminating life support measures.
There are excellent reasons to assess the severity of brain 
injury early after a cardiac arrest. First, triage to individualized 
treatment pathways based on the type and severity of brain, 
cardiac, and systemic injuries, with an analysis of competing 
risks may improve both outcomes and resource utilization 
(2). Second, families require accurate information to make 
informed decisions about the therapeutic options they are 
offered. Finally, the increasing number of patients surviving 
an OHCA (3) mandates that effective but expensive therapies 
like prolonged temperature management and coronary revas-
cularization be targeted to patients likely to benefit, rather than 
simply anyone rolling through the door with a pulse. We need 
an early assessment of brain injury to provide, as we like to say, 
the “right care, right now.”
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